82 related articles for article (PubMed ID: 22076108)
1. Comparison of experimentally determined and mathematically predicted percutaneous penetration rates of chemicals.
Korinth G; Schaller KH; Bader M; Bartsch R; Göen T; Rossbach B; Drexler H
Arch Toxicol; 2012 Mar; 86(3):423-30. PubMed ID: 22076108
[TBL] [Abstract][Full Text] [Related]
2. Potential of the octanol-water partition coefficient (logP) to predict the dermal penetration behaviour of amphiphilic compounds in aqueous solutions.
Korinth G; Wellner T; Schaller KH; Drexler H
Toxicol Lett; 2012 Nov; 215(1):49-53. PubMed ID: 23026264
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies between different rat models for the assessment of percutaneous penetration of hazardous substances.
Korinth G; Göen T; Schaller KH; Drexler H
Arch Toxicol; 2007 Dec; 81(12):833-40. PubMed ID: 17576541
[TBL] [Abstract][Full Text] [Related]
4. Organic compounds percutaneous penetration in vivo in man: Relationship to mathematical predictive model.
Burli A; Law RM; Rodriguez J; Maibach HI
Regul Toxicol Pharmacol; 2020 Apr; 112():104614. PubMed ID: 32044383
[TBL] [Abstract][Full Text] [Related]
5. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
Bo Nielsen J; Ahm Sørensen J; Nielsen F
J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
[TBL] [Abstract][Full Text] [Related]
6. Ability of mathematical models to predict human in vivo percutaneous penetration of steroids.
Burli A; Law RM; Maibach HI
Regul Toxicol Pharmacol; 2021 Nov; 126():105041. PubMed ID: 34499979
[TBL] [Abstract][Full Text] [Related]
7. Comparison of models for the estimation of biological partition coefficients.
Payne MP; Kenny LC
J Toxicol Environ Health A; 2002 Jul; 65(13):897-931. PubMed ID: 12133236
[TBL] [Abstract][Full Text] [Related]
8. In-silico model of skin penetration based on experimentally determined input parameters. Part II: mathematical modelling of in-vitro diffusion experiments. Identification of critical input parameters.
Naegel A; Hansen S; Neumann D; Lehr CM; Schaefer UF; Wittum G; Heisig M
Eur J Pharm Biopharm; 2008 Feb; 68(2):368-79. PubMed ID: 17766097
[TBL] [Abstract][Full Text] [Related]
9. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.
Roberts WJ; Sloan KB
J Pharm Sci; 2000 Nov; 89(11):1415-31. PubMed ID: 11015687
[TBL] [Abstract][Full Text] [Related]
10. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
11. Is the permeability coefficient Kp a reliable tool in percutaneous absorption studies?
Korinth G; Schaller KH; Drexler H
Arch Toxicol; 2005 Mar; 79(3):155-9. PubMed ID: 15627196
[TBL] [Abstract][Full Text] [Related]
12. Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.
Roberts WJ; Sloan KB
J Pharm Sci; 1999 May; 88(5):515-22. PubMed ID: 10229642
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity studies of Ethylene Glycol Ethers: 2-Methoxyethanol, 2-Ethoxyethanol, 2-Butoxyethanol (CAS Nos. 109-86-4, 110-80-5, 111-76-2) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice.
Dieter M
Toxic Rep Ser; 1993 Jul; 26():1-G15. PubMed ID: 12209180
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of percutaneous penetration of aniline and o-toluidine in vitro using skin barrier creams.
Korinth G; Lüersen L; Schaller KH; Angerer J; Drexler H
Toxicol In Vitro; 2008 Apr; 22(3):812-8. PubMed ID: 18155878
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption.
Brown MB; Lau CH; Lim ST; Sun Y; Davey N; Moss GP; Yoo SH; De Muynck C
J Pharm Pharmacol; 2012 Apr; 64(4):566-77. PubMed ID: 22420662
[TBL] [Abstract][Full Text] [Related]
16. Designing for topical delivery: prodrugs can make the difference.
Sloan KB; Wasdo S
Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the thermogravimetric analysis (TGA) and Franz cell methods to assess dermal diffusion of volatile chemicals.
Rauma M; Johanson G
Toxicol In Vitro; 2009 Aug; 23(5):919-26. PubMed ID: 19379803
[TBL] [Abstract][Full Text] [Related]
18. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
Fasano WJ; McDougal JN
Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol.
Cnubben NH; Elliott GR; Hakkert BC; Meuling WJ; van de Sandt JJ
Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):198-208. PubMed ID: 12052004
[TBL] [Abstract][Full Text] [Related]
20. Prediction of percutaneous absorption from physicochemical data: a model based on data of in vitro experiments.
Sartorelli P; Aprea C; Cenni A; Novelli MT; Orsi D; Palmi S; Matteucci G
Ann Occup Hyg; 1998 May; 42(4):267-76. PubMed ID: 9713250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
